Market Tracker

08/22 3:36am ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

6.91
Data as of Aug 21
 -0.10 / -1.43%
Today’s Change
5.40
Today|||52-Week Range
11.88
-6.50%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close7.01
Today’s open6.99
Day’s range-- - --
Volume59,000
Average volume (3 months)68,976
Market cap$304.2M
Dividend yield--
Data as of 08/21/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-106.46%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratioNM
Price/Sales14.53
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
TTPHTetraphase Pharmaceu...-0.15-1.28%
XNPTXenoport Inc-0.10-2.07%
ADMSAdamas Pharmaceutica...+0.44+2.45%
SVASinovac Biotech Ltd-0.00-0.09%
Data as of 3:59pm ET, 08/21/2014

Financials

Next reporting dateNovember 12, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts